Jaguar Health, Inc.
USD3.00
+0.04 (+1.35%)
CEO
Lisa A. Conte
IPO Date
2015-05-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.95
Prev. Close
$2.96
Day Low
$2.92
Day High
$3.00
52W Low
$2.12
52W High
$97.65
Market Cap
$0.00B
Volume
0.02M
| -0.2 |
| 31 Dec 2023 | FY | 79.1% | -423.1% | -832.5% | -81.4% | 7.48 | 2.00 | -0.0 |
| 31 Dec 2022 | FY | 83.1% | -396.9% | 7222.8% | -100.0% | -53.02 | 0.74 | -0.1 |
| 31 Dec 2021 | FY | 46.2% | -1213.3% | -453.0% | -98.7% | 2.53 | 1.84 | -0.3 |
| 31 Dec 2020 | FY | 65.1% | -360.2% | -196.5% | -78.9% | 0.94 | 1.35 | -0.3 |
| 31 Dec 2019 | FY | 33.9% | -667.3% | -361.1% | -105.8% | 0.71 | 0.62 | 0.0 |
| 31 Dec 2018 | FY | 37.4% | -727.9% | -597.2% | -78.3% | 2.99 | 0.31 | 0.0 |
| 31 Dec 2017 | FY | 79.8% | -503.7% | -127.3% | -50.4% | 0.95 | 0.25 | 0.0 |
| 31 Dec 2016 | FY | 63.3% | -10410.9% | 600.4% | -413.5% | -1.58 | 0.61 | 0.0 |
| -0.1 |
| 30 Sept 2025 | Q3 | 82.7% | -308.2% | -168.9% | -19.2% | 5.67 | 0.81 | -0.1 |
| 30 Jun 2025 | Q2 | 82.3% | -349.3% | -130.3% | -21.6% | 3.82 | 0.95 | -0.1 |
| 31 Mar 2025 | Q1 | 76.7% | -472.6% | -587.2% | -20.3% | 21.51 | 1.08 | -0.1 |
| 31 Dec 2024 | Q4 | 84.1% | -282.7% | -136.2% | -18.6% | 5.01 | 1.63 | -0.3 |
| 30 Sept 2024 | Q3 | 82.6% | -317.1% | -72.4% | -16.9% | 2.52 | 1.84 | -0.3 |
| 30 Jun 2024 | Q2 | 84.3% | -348.8% | -49.0% | -15.4% | 1.76 | 2.10 | -0.1 |
| 31 Mar 2024 | Q1 | 81.7% | -392.4% | -63.7% | -16.7% | 2.31 | 1.89 | -0.1 |
| 31 Dec 2023 | Q4 | 70.1% | -398.7% | -184.8% | -18.1% | 7.48 | 2.00 | -0.1 |